Trial Profile
Antiviral Activity of Peg-IFN-Alpha-2A in Chronic HIV-1 Infection
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Peginterferon alfa-2a (Primary) ; Antiretrovirals
- Indications HIV-1 infections
- Focus Therapeutic Use
- 08 Mar 2012 Results presented at the 19th Conference on Retroviruses and Opportunistic Infections.
- 25 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Dec 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.